FF:0000513: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
|is_obsolete= | |is_obsolete= | ||
|located_in= | |located_in= | ||
|name=J2E erythroblastic leukemia line 48hr after treatment with erythropoietin | |name=mouse J2E erythroblastic leukemia line 48hr after treatment with erythropoietin sample | ||
|namespace=FANTOM5 | |namespace=FANTOM5 | ||
|obo_creation_date= | |obo_creation_date= | ||
Latest revision as of 16:56, 12 September 2014
outline
- id: FF:0000513
- name: mouse J2E erythroblastic leukemia line 48hr after treatment with erythropoietin sample
- namespace: FANTOM5
- CAGEd oPOSSUM: NA
Ontology association
Parents
| is_a: | EFO:0001746(development or differentiation design),FF:0000337(erythropoietin treatment sample),FF:0000350(experimentally modified sample),FF:0000375(48 hr sample),FF:0000403(mouse J2E erythroblastic leukemia cell line sample) |
|---|
Children
| is a: | FF:13078-140A9 (J2E erythroblastic leukemia response to erythropoietin),FF:13144-140I3 (J2E erythroblastic leukemia response to erythropoietin),FF:13210-141G6 (J2E erythroblastic leukemia response to erythropoietin) |
|---|
FF Samples
Mouse
- 13078-140A9 (J2E erythroblastic leukemia response to erythropoietin)
- 13144-140I3 (J2E erythroblastic leukemia response to erythropoietin)
- 13210-141G6 (J2E erythroblastic leukemia response to erythropoietin)
